Silver nanowires as prospective carriers for drug delivery in cancer treatment: An in vitro biocompatibility study on lung adenocarcinoma cells and fibroblasts

European Journal of Nanomedicine

Volumn 5, Issue 4, 2013, Pages 195-204

  Singh, Manisha ^a   Movia, Dania ^a,b   Mahfoud, Omar K ^a   Volkov, Yuri ^a,b   Prina Mello, Adriele ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

cell cycle; cytotoxicity; fibroblasts; lung adenocarcinoma cells; silver nanowires

Indexed keywords

ADENOCARCINOMA CELLS; BIOCHEMICAL PROPERTIES; BIOMEDICAL APPLICATIONS; CELL CYCLE; LUNG CANCER THERAPY; NANOMATERIAL; PHYSICO-CHEMICALS; SILVER NANOWIRES;

BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CELL CULTURE; CYTOTOXICITY; DISEASE CONTROL; DRUG DELIVERY; ELECTRIC RESISTANCE MEASUREMENT; FIBROBLASTS; MEDICAL APPLICATIONS;

DISEASES;

NANOWIRE; SILVER NANOWIRE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL POPULATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FIBROBLAST; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; LUNG ADENOCARCINOMA;

EID: 84890418007     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2013-0024     Document Type: Article

References (73)

1. Lung Cancer 2011. Available from: http://www.ncri.ie/pubs/pubfiles/ LungCancer2011.pdf.
2. Huber RM, Stratakis DF. Molecular oncology-perspectives in lung cancer. Lung cancer (Amsterdam, Netherlands) 2004;45(Suppl 2): S209-13.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 2013;63:11-30.
4. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy for non-small cell lung cancer. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002139. DOI: 10.1002/14651858.CD002139.
5. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011;12:175-80.
6. Kumar M, Nagpal R, Hemalatha R, Verma V, Kumar A, Singh S, et al. Targeted cancer therapies: the future of cancer treatment. Acta Bio-medica: Atenei Parmensis 2012;83:220-33.
7. General Information About Non-Small Cell Lung Cancer. Available from: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/Patient/ page1.
8. Reck M, Heigener DF, Mok T, Soria JC, Rabe KF. Management of non-small-cell lung cancer: recent developments. Lancet 2013;382:709-19.
9. Da Silva AL, Santos RS, Xisto DG, Alonso Sdel V, Morales MM, Rocco PR. Nanoparticle-based therapy for respiratory diseases. Anais da Academia Brasileira de Ciencias 2013;85:137-46.
10. Kurmi BD, Kayat J, Gajbhiye V, Tekade RK, Jain NK. Micro- and nanocarrier-mediated lung targeting. Expert Opin Drug Deliver 2010;7:781-94.
11. Zarogoulidis P, Chatzaki E, Porpodis K, Domvri K, Hohenforst- Schmidt W, Goldberg EP, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine 2012;7:1551-72.
12. Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 2006;107:459-66.
13. Ravindran A, Chandran P, Khan SS. Biofunctionalized silver nanoparticles: advances and prospects. Colloid Surface B, Biointerfaces 2013;105:342-52.
14. Bhattacharya R, Mukherjee P. Biological properties of "naked" metal nanoparticles. Adv Drug Deliver Rev 2008;60:1289-306.
15. Liao H, Nehl CL, Hafner JH. Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine (London, England) 2006;1:201-8.
16. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns: J Int Soc Burn Injuries 2007;33:139-48.
17. Arvizo RR, Bhattacharyya S, Kudgus RA, Giri K, Bhattacharya R, Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 2012;41:2943-70.
18. Volker C, Oetken M, Oehlmann J. The biological effects and possible modes of action of nanosilver. Reviews of environmental contamination and toxicology 2013;223:81-106.
19. Prabhu S, Poulose E. Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects. Int Nano Lett 2012;2:1-10. (English).
20. Samuel U, Guggenbichler JP. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Ag 2004;23(Suppl 1):S75-8.
21. Kalishwaralal K, Barathmanikanth S, Pandian SR, Deepak V, Gurunathan S. Silver nano-a trove for retinal therapies. J Control Release: Official J Control Release Society 2010;145:76-90.
22. Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology 2010;8:1.
23. de Mel A, Chaloupka K, Malam Y, Darbyshire A, Cousins B, Seifalian AM. A silver nanocomposite biomaterial for blood-contacting implants. J Biomed Mater Res Part A 2012;100:2348-57.
24. Naghavi N, de Mel A, Alavijeh OS, Cousins BG, Seifalian AM. Nitric oxide donors for cardiovascular implant applications. Small (Weinheim an der Bergstrasse, Germany) 2013;9:22-35.
25. Sessa WC. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemostasis 2009;7(Suppl 1):35-7.
26. Halpenny GM, Gandhi KR, Mascharak PK. Eradication of pathogenic bacteria by remote delivery of nitric oxide via lighttriggering of nitrosyl-containing materials. ACS Med Chem Lett 2010;1:180-3.
27. Hecht DS, Hu L, Irvin G. Emerging transparent electrodes based on thin films of carbon nanotubes, graphene, and metallic nanostructures. Adv Mater (Deerfield Beach, Fla) 2011;23: 1482-513.
28. Xu F, Zhu Y. Highly conductive and stretchable silver nanowire conductors. Adv Mater (Deerfield Beach, Fla) 2012;24:5117-22.
29. Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, et al. Nanowired three-dimensional cardiac patches. Nature Nanotechnology 2011;6:720-5.
30. Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J Nanobiotechnology 2013;11:5.
31. Dreaden EC, El-Sayed MA. Detecting and destroying cancer cells in more than one way with noble metals and different confinement properties on the nanoscale. Accounts Chem Res 2012;45:1854-65.
32. Jeyaraj M, Sathishkumar G, Sivanandhan G, MubarakAli D, Rajesh M, Arun R, et al. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloid Surface B, Biointerfaces 2013;106:86-92.
33. Homan KA, Souza M, Truby R, Luke GP, Green C, Vreeland E, et al. Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano 2012;6:641-50.
34. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003;27:341-53.
35. Payne CM, Bladin C, Colchester AC, Bland J, Lapworth R, Lane D. Argyria from excessive use of topical silver sulphadiazine. Lancet 1992;340:126.
36. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006;60:648-52.
37. Stensberg MC, Wei Q, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (London, England) 2011;6:879-98.
38. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011;85:743-50.
39. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briede JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011;32:9810-7.
40. Costa CS, Ronconi JV, Daufenbach JF, Goncalves CL, Rezin GT, Streck EL, et al. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem 2010;342:51-6.
41. Suresh AK, Pelletier DA, Wang W, Morrell-Falvey JL, Gu B, Doktycz MJ. Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir: ACS J Surf Colloid 2012;28:2727-35.
42. Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat Res 2011;726:129-35.
43. Stoehr LC, Gonzalez E, Stampfl A, Casals E, Duschl A, Puntes V, et al. Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol 2011;8:36.
44. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008;179:93-100.
45. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011;201: 92-100.
46. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;3:279-90.
47. Perry MM, Hui CK, Whiteman M, Wood ME, Adcock I, Kirkham P, et al. Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am J Resp Cell Mol 2011;45:746-52.
48. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ. Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 2012;12:4271-5.
49. Kermanizadeh A, Gaiser BK, Hutchison GR, Stone V. An in vitro liver model-assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials. Part Fibre Toxicol 2012;9:28.
50. Kermanizadeh A, Pojana G, Gaiser BK, Birkedal R, Bilanicova D, Wallin H, et al. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers. Nanotoxicology 2013;7: 301-13.
51. Kermanizadeh A, Brown DM, Hutchison GR, Stone V. Engineered nanomaterial impact in the liver following exposure via an intravenous route-the role of polymorphonuclear leukocytes and gene expression in the organ. J Nanomed Nanotechol 2013;4:157.
52. Verma NK, Conroy J, Lyons PE, Coleman J, O'Sullivan MP, Kornfeld H, et al. Autophagy induction by silver nanowires: a new aspect in the biocompatibility assessment of nanocomposite thin films. Toxicol Appl Pharmacol 2012;264:451-61.
53. Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, et al. The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci: An Off J Soc Toxicol 2012;128:461-70.
54. Nowack B, Krug HF, Height M. 120 years of nanosilver history: implications for policy makers. Environ Sci Tech 2011;45: 1177-83.
55. Schafer B, Brocke JV, Epp A, Gotz M, Herzberg F, Kneuer C, et al. State of the art in human risk assessment of silver compounds in consumer products: a conference report on silver and nanosilver held at the BfR in 2012. Arch Toxicol 2013: DOI: 10.1007/s00204-013-1083-8.
56. Kim B, Park CS, Murayama M, Hochella MF. Discovery and characterization of silver sulfide nanoparticles in final sewage sludge products. Environ Sci Tech 2010;44:7509-14.
57. Nowack B. Chemistry. Nanosilver revisited downstream. Science (New York, NY) 2010;330:1054-5.
58. Liu J, Pennell KG, Hurt RH. Kinetics and mechanisms of nanosilver oxysulfidation. Environ Sci Tech 2011;45:7345-53.
59. Levard C, Reinsch BC, Michel FM, Oumahi C, Lowry GV, Brown GE. Sulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rate. Environ Sci Tech 2011;45:5260-6.
60. Levard C, Hotze EM, Lowry GV, Brown GE, Jr. Environmental transformations of silver nanoparticles: impact on stability and toxicity. Environ Sci Tech 2012;46:6900-14.
61. Schinwald A, Donaldson K. Use of back-scatter electron signals to visualise cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fibres in macrophages and compartmentalisation in mesothelial cells in vivo. Part Fibre Toxicol 2012;9:34.
62. Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (London, England) 2011;6:143-56.
63. Schinwald A, Chernova T, Donaldson K. Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part Fibre Toxicol 2012;9:47.
64. Shapiro DL, Nardone LL, Rooney SA, Motoyama EK, Munoz JL. Phospholipid biosynthesis and secretion by a cell line (A549) which resembles type II aleveolar epithelial cells. Biochimica et biophysica acta 1978;530:197-207.
65. Mohamed BM, Movia D, Knyazev A, Langevin D, Davies AM, Prina-Mello A, et al. Citrullination as early-stage indicator of cell response to single-walled carbon nanotubes. Sci Rep 2013;3:1124.
66. Mohamed BM, Verma NK, Davies AM, McGowan A, Crosbie- Staunton K, Prina-Mello A, et al. Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo. Nanomedicine (London, England) 2012;7:1181-95.
67. Mohamed BM, Verma NK, Prina-Mello A, Williams Y, Davies AM, Bakos G, et al. Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology 2011;9:29.
68. Verma NK, Crosbie-Staunton K, Satti A, Gallagher S, Ryan KB, Doody T, et al. Magnetic core-shell nanoparticles for drug delivery by nebulization. J Nanobiotechnology 2013;11:1.
69. Caino MC, Lopez-Haber C, Kissil JL, Kazanietz MG. Non-small cell lung carcinoma cell motility, rac activation and metastatic dissemination are mediated by protein kinase C epsilon. PLoS One 2012;7:e31714.
70. Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 2008;4:1075-89.
71. Donaldson K. The inhalation toxicology of p-aramid fibrils. Cr Rev Toxicol 2009;39:487-500.
72. Liu J, Sonshine DA, Shervani S, Hurt RH. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 2010;4:6903-13.
73. Kim S, Ryu DY. Silver nanoparticle-induced oxidative stress, genotoxicity and apoptosis in cultured cells and animal tissues. J Appl Toxicol 2013;33:78-89.